MA35730B1 - Nouveaux supports d'agent actif à libération contrôlée, à enrobage - Google Patents

Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Info

Publication number
MA35730B1
MA35730B1 MA37114A MA37114A MA35730B1 MA 35730 B1 MA35730 B1 MA 35730B1 MA 37114 A MA37114 A MA 37114A MA 37114 A MA37114 A MA 37114A MA 35730 B1 MA35730 B1 MA 35730B1
Authority
MA
Morocco
Prior art keywords
coating
new active
calcium carbonate
natural
release
Prior art date
Application number
MA37114A
Other languages
English (en)
Inventor
Patrick A C Gane
Patrick Schwarzentruber
Maiuta Nicola Di
Joachim Schoelkopf
Catherine Jean Ridgway
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/072161 external-priority patent/WO2013068478A1/fr
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MA35730B1 publication Critical patent/MA35730B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Paints Or Removers (AREA)

Abstract

La présente invention concerne des supports pour la libération contrôlée d'agents actifs, comprenant un noyau, comprenant du carbonate de calcium naturel ou synthétique ayant réagi en surface, et au moins un agent actif, ledit ou lesdits agent(s) actif(s) étant associé(s) audit carbonate de calcium ayant réagi en surface, naturel ou synthétique, et ledit carbonate de calcium naturel ou synthétique, ayant réagi en surface, étant un produit de réaction de carbonate de calcium naturel ou synthétique avec du dioxyde de carbone et un ou plusieurs acide(s), le dioxyde de carbone étant formé
MA37114A 2011-11-10 2014-06-06 Nouveaux supports d'agent actif à libération contrôlée, à enrobage MA35730B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (fr) 2011-11-10 2011-11-10 Nouveaux supports revêtus d'agent actif à libération contrôlée
PCT/EP2012/072161 WO2013068478A1 (fr) 2011-11-10 2012-11-08 Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Publications (1)

Publication Number Publication Date
MA35730B1 true MA35730B1 (fr) 2014-12-01

Family

ID=44992702

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37114A MA35730B1 (fr) 2011-11-10 2014-06-06 Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Country Status (3)

Country Link
EP (2) EP2591772B1 (fr)
MA (1) MA35730B1 (fr)
TN (1) TN2014000141A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3016464A1 (fr) 2016-03-08 2017-09-14 Soo-Young Kang Compositions cosmetiques longue duree
CA3074845A1 (fr) 2017-09-13 2019-03-21 Living Proof, Inc. Compositions de protection de couleur
AU2018333932B2 (en) 2017-09-13 2024-05-02 Living Proof, Inc. Long lasting cosmetic compositions
WO2019099966A1 (fr) 2017-11-20 2019-05-23 Living Proof, Inc. Propriétés permettant d'obtenir des performances cosmétiques de longue durée
CN109846043B (zh) * 2017-11-30 2023-04-07 内蒙古伊利实业集团股份有限公司 一种结肠缓释益生菌及其制备方法
CN112041365A (zh) 2018-04-27 2020-12-04 生活实验公司 持久性化妆品组合物
US11896685B2 (en) 2018-10-31 2024-02-13 Amorepacific Corporation Core-shell network structure comprising biopolymer and composition comprising same
KR20200049662A (ko) * 2018-10-31 2020-05-08 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
EP3928859A1 (fr) 2020-06-23 2021-12-29 Omya International AG Carbonate de calcium traité par réaction en surface dans un procédé de production d'une microcapsule chargée

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (fr) 2006-08-25 2008-02-27 Novartis AG Formulations galéniques de l'aliskiren
EP1974807B1 (fr) * 2007-03-21 2010-03-03 Omya Development Ag Processus de suppression de composés à perturbations endocrines
DK2070991T3 (da) 2007-12-12 2010-12-20 Omya Development Ag Fremgangsmåde til frembringelse af overflademodificeret, udfældet calciumcarbonat
EP2168572A1 (fr) * 2008-09-30 2010-03-31 Omya Development Ag Nouveau support d'agent actif à libération contrôlée
EP2421507B1 (fr) 2009-04-24 2019-01-23 Fertin Pharma A/S Gomme à mâcher et matière particulaire pour la libération contrôlée de principes actifs
EP2264109B1 (fr) 2009-06-15 2012-01-25 Omya Development AG Procédé de préparation de carbonate de calcium à réaction en surface, et son utilisation
PL2264108T3 (pl) 2009-06-15 2012-07-31 Omya Int Ag Sposób wytwarzania przereagowanego powierzchniowo węglanu wapnia, z wykorzystaniem słabego kwasu

Also Published As

Publication number Publication date
TN2014000141A1 (en) 2015-09-30
EP2591772A1 (fr) 2013-05-15
EP3075376A1 (fr) 2016-10-05
EP2591772B1 (fr) 2016-05-04

Similar Documents

Publication Publication Date Title
MA35730B1 (fr) Nouveaux supports d'agent actif à libération contrôlée, à enrobage
FR2929271B1 (fr) Procede pour la preparation du 1,2,3,3,3-pentafluoropropene- 1
UA104601C2 (uk) Модулятори регулятора трансмембранної провідності при муковісцидозі
MY168425A (en) New coated controlled release active agent carriers
BR112012016749A2 (pt) "d-aminoácido para uso no tratamento de biofilmes"
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
MA34488B1 (fr) Composition pesticides
UA104869C2 (uk) Фармацевтичні композиції, що містять ліганди рецептора дофаміну
GB2460597A (en) N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
ME00814B (me) NOVI POSTUPAK SINTEZE 7,8-DIMETOKSI-1 ,3-DIHIDR0-2H-3-BENZAZEPIN-2-ON-a l PRIMENA U SINTEZI IVABRADINA l NJEGOVIH ADICIONIH SOLI SA FARMACEUTSKI PRIHVATLJIVOM KISELINOM
MX363408B (es) Composicion que contiene peroxido y acido peracetico y proceso para matar esporas.
PH12018502133A1 (en) Conjugated c1 esterase inhibitor and uses thereof
MX2010004962A (es) Mezclas homogeneas y estables en almacenamiento de diferentes particulas de granulos de agentes activos protectores de plantas.
EA201100773A1 (ru) Применение ассоциации ингибитора тока синусного узла iи ингибитора ангиотензинпревращающего фермента для лечения сердечной недостаточности
GEP20125680B (en) Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydra-zinium) ropionate esters and their use for 3-(2,2,2-rimethyl- hydrazinium) propionate dihydrate preparation
SG195170A1 (en) Methods of treating or preventing rheumatic disease
UA103747C2 (ru) Ароматические соединения с повышенной стабильностью
WO2011127244A8 (fr) Formulations de sulfate d'atazanavir avec un effet ph amélioré
EA201300719A2 (ru) Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина и применение в синтезе ивабрадина и его солей
MX344965B (es) Preparacion de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilam ino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopropan-1-sulfonam ida y derivados protegidos de los mismos.
WO2014065640A3 (fr) Composition pour le traitement ou la prévention de maladies inflammatoires contenant un extrait de myagropsis myagroides ou fraction de celui-ci comme principe actif
WO2007088051A3 (fr) Modulation de l'activite mdl-1 pour le traitement de maladies inflammatoires
WO2009158387A3 (fr) Compositions, formulations, et procédés permettant de prévenir et/ou de traiter des effets physiques de la consommation d'alcool
CL2009000811A1 (es) Polipeptido con actividad antimicrobiana que comprende una secuencia aminoacidica de al menos un 90% de identidad con la secuencia id no:1 para producir un medicamento para tratar la meningitis; uso de dicho polipeptido para tratar la meningitis.